Indications
Treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).
Composition
- Active substance
- naloxegol oxalate
- International name (INN)
- naloxegol
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Moventig
- Active substance
- naloxegol oxalate
- ATC code
- A06AH03
- Therapeutic area
- Constipation, Opioid-Related Disorders
- Marketing authorisation holder
- Grunenthal GmbH
- Status
- Authorised